Skip to content

Clinical efficacy of hand foot Wentong ointment in the treatment of hand foot syndrome caused by chemotherapy drugs

Clinical efficacy of hand foot Wentong ointment in the treatment of hand foot syndrome caused by chemotherapy drugs

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004965
Enrollment
Unknown
Registered
2021-06-20
Start date
2021-06-21
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand foot syndrome

Interventions

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with malignant tumors confirmed by pathology or cytology; 2. Patients with grade 1 or above HFS after receiving chemotherapy; 3. Komofsky score > 60 points; 4. No serious heart, liver, kidney and other important organ dysfunction; 5. The expected survival period is more than 3 months; 6. Aged 18-80 years; 7. Good compliance; 8. Voluntarily participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Those with preexisting nervous system diseases; 2. Diabetes complicated with nervous system diseases; 3. Patients who are receiving other non-chemotherapy drugs that may cause neurotoxicity; 4. Uncontrolled infections and metabolic diseases; 5. Pregnant women or mentally ill patients.

Design outcomes

Primary

MeasureTime frame
Overall efficiency of HFS improvement;

Secondary

MeasureTime frame
Improvement score of common symptoms of tumor;Improvement of quality of life score;

Countries

China

Contacts

Public ContactChen Gang

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

dragonchengang@sina.com+86 13871560923

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026